Oxford BioDynamics and Goodbody Clinic launch prostate screening blood test in UK 23-May-2024 By Isabel Cameron Oxford BioDynamics, a biotech company specializing in precision medicine tests via the EpiSwitch 3D genomics platform, has partnered with the Goodbody Clinic, a provider of private health testing services.
Convergent Therapeutics secures $90M to accelerate radiopharmaceuticals treatment for prostate cancer 09-May-2023 By Isabel Cameron Convergent Therapeutics has raised $90 million to develop next-generation radiopharmaceuticals for the treatment of cancer.
Dendreon makes leap to become cell therapy CMO 25-Jun-2021 By Ben Hargreaves Dendreon pivots to become a contract manufacturer of late-stage cell therapies, centered on its Seal Beach facility.
